Literature DB >> 20824263

[Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].

A Heratizadeh1, B Völker, E Kupsch, K Wichmann, A Kapp, T Werfel.   

Abstract

A 19-year-old patient presented with epidermodysplasia verruciformis (EV). In this genodermatosis, pathogenetic factors such as infection by human papilloma viruses as well as sun exposure are considered responsible for the malignant transformation of EV lesions to skin cancer within decades. So far, several therapeutic strategies have been unsatisfactory. In our case HPV 5b was detected and the associated skin lesions were successfully treated with imiquimod 5% cream.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20824263     DOI: 10.1007/s00105-010-1998-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  20 in total

1.  Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod.

Authors:  Kathleen Janssen; Georges P H Lucker; Ronald H Houwing; R van Rijssel
Journal:  Int J Dermatol       Date:  2007-11       Impact factor: 2.736

2.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

3.  Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.

Authors:  Nicolas Ramoz; Luis-Alfredo Rueda; Bakar Bouadjar; Luz-Stella Montoya; Gérard Orth; Michel Favre
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

Review 4.  Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations?

Authors:  Slawomir Majewski; Stefania Jablonska
Journal:  Arch Dermatol       Date:  2002-05

5.  Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Authors:  K Sotlar; D Diemer; A Dethleffs; Y Hack; A Stubner; N Vollmer; S Menton; M Menton; K Dietz; D Wallwiener; R Kandolf; B Bültmann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding.

Authors:  Gian Paolo Marcuzzi; Martin Hufbauer; Hans Udo Kasper; Sönke Jan Weißenborn; Sigrun Smola; Herbert Pfister
Journal:  J Gen Virol       Date:  2009-08-19       Impact factor: 3.891

7.  Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.

Authors:  Cindy Berthelot; Mary C Dickerson; Peter Rady; Qin He; Farhad Niroomand; Stephen K Tyring; Amit G Pandya
Journal:  J Am Acad Dermatol       Date:  2007-03-26       Impact factor: 11.527

Review 8.  Epidermodysplasia verruciformis and human papilloma virus.

Authors:  Aron Gewirtzman; Brenda Bartlett; Stephen Tyring
Journal:  Curr Opin Infect Dis       Date:  2008-04       Impact factor: 4.915

9.  Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A.

Authors:  Peter Wolf; Hannes Seidl; Barbara Bäck; Barbara Binder; Gerald Höfler; Franz Quehenberger; Christine Hoffmann; Helmut Kerl; Sabine Stark; Herbert J Pfister; Pawel G Fuchs
Journal:  Arch Dermatol       Date:  2004-03

10.  Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18.

Authors:  S Giampieri; A Storey
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

View more
  2 in total

1.  Efficacy of oral zinc therapy in epidermodysplasia verruciformis with squamous cell carcinoma.

Authors:  Sudhanshu Sharma; Krishna Deb Barman; Rashmi Sarkar; Mukesh Manjhi; Vijay Kumar Garg
Journal:  Indian Dermatol Online J       Date:  2014-01

2.  Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.

Authors:  Rui Yoshida; Toshihiko Kato; Masahiko Kawase; Mariko Honda; Tsuyoshi Mitsuishi
Journal:  BMC Dermatol       Date:  2014-07-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.